{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:39:05Z","timestamp":1786995545166,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pcd.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T17:36:08Z","timestamp":1591637768000},"page":"639-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare"],"prefix":"10.1016","volume":"14","author":[{"given":"Maria","family":"Hagn\u00e4s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Sundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tumminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Frittitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Mikkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2020.05.005_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2020.05.005_bib0010","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int. Suppl."},{"issue":"2016","key":"10.1016\/j.pcd.2020.05.005_bib0015","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"European guidelines on cardiovascular disease prevention in clinical practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcd.2020.05.005_bib0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/aje\/kwh232","article-title":"Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: national health and nutrition examination surveys, 1971\u20132000","volume":"160","author":"Imperatore","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.pcd.2020.05.005_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.pcd.2020.05.005_bib0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pcd.2020.05.005_bib0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-007-0616-1","article-title":"Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study","volume":"50","author":"Bruno","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2020.05.005_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/ijcp.12640","article-title":"Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study","volume":"69","author":"Ruzafa","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.pcd.2020.05.005_bib0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5694\/j.1326-5377.2006.tb00499.x","article-title":"The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)","volume":"185","author":"Thomas","year":"2006","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.pcd.2020.05.005_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000487500","article-title":"A prospective cohort study in patients with type 2 diabetes mellitus for validation of biomarkers (PROVALID) \u2013 study design and baseline characteristics","volume":"43","author":"Eder","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.pcd.2020.05.005_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2369-14-46","article-title":"Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study","volume":"14","author":"Rodriguez-Poncelas","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.pcd.2020.05.005_bib0060","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2016.14282","article-title":"Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs","author":"Lamine","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.pcd.2020.05.005_bib0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pcd.2014.06.001","article-title":"High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care","volume":"9","author":"Mets\u00e4rinne","year":"2015","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2020.05.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110535","article-title":"Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease)","volume":"9","author":"Szczech","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pcd.2020.05.005_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcd.2020.02.006","article-title":"Clinical update: the important role of dual kidney function testing (ACR and eGFR) in primary care: identification of risk and management in type 2 diabetes","author":"Seidu","year":"2020","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2020.05.005_bib0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000256","article-title":"Chronic kidney disease in low-income to middle-income countries: the case for increased screening","volume":"2","author":"George","year":"2017","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.pcd.2020.05.005_bib0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11739-016-1425-7","article-title":"Prevention programs for chronic kidney disease in low-income countries","volume":"11","author":"Perico","year":"2016","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.pcd.2020.05.005_bib0090","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2020.05.005_bib0095","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials","volume":"343","author":"Boussageon","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.pcd.2020.05.005_bib0100","first-page":"A4502","article-title":"Screening for microalbuminuria in patients with type 2 diabetes is incomplete in general practice","volume":"59","author":"Knudsen","year":"2012","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.pcd.2020.05.005_bib0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcd.2020.05.005_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00125-018-4801-1","article-title":"Cardiovascular outcome trials of glucose-lowering medications: an update","volume":"62","author":"Home","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2020.05.005_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pcd.2018.09.001","article-title":"Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: a national cross sectional study","volume":"13","author":"Manski-Nankervis","year":"2019","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.pcd.2020.05.005_bib0120","first-page":"24","article-title":"Prescribing for older people with chronic renal impairment","volume":"42","author":"Bell","year":"2013","journal-title":"Aust. Fam. Physician"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199182030190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175199182030190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:59:08Z","timestamp":1761695948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S175199182030190X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S175199182030190X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2020.05.005","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}